Mercury Laboratories Ltd. | Small-cap | Healthcare
₹856.00
-0.56%
| Mercury Laboratories Stock Comparison:

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 751.0M
Gross Profit 461.9M 61.50%
Operating Income 41.4M 5.51%
Net Income 31.4M 4.19%

Balance Sheet Metrics

Total Assets 742.4M
Total Liabilities 206.7M
Shareholders Equity 535.7M
Debt to Equity 0.39

Cash Flow Metrics

Operating Cash Flow -12.6M
Free Cash Flow -50.4M

Revenue & Profitability Trend

Mercury Laboratories Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 751.0M 755.6M 753.3M 579.2M 686.0M
Cost of Goods Sold 289.2M 305.4M 306.1M 237.6M 313.8M
Gross Profit 461.9M 450.2M 447.3M 341.6M 372.3M
Operating Expenses 223.3M 199.8M 213.6M 143.2M 157.1M
Operating Income 41.4M 76.6M 66.0M 47.8M 92.2M
Pre-tax Income 46.6M 69.2M 74.4M 50.3M 79.1M
Income Tax 15.2M 12.7M 18.7M 14.7M 25.7M
Net Income 31.4M 56.5M 55.8M 35.6M 53.4M
EPS (Diluted) - ₹47.12 ₹46.49 ₹29.68 ₹44.48

Income Statement Trend

Mercury Laboratories Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 400.8M 398.4M 394.6M 352.2M 378.0M
Non-Current Assets 341.6M 281.2M 247.1M 272.1M 275.7M
Total Assets 742.4M 679.6M 641.6M 624.3M 653.7M
Liabilities
Current Liabilities 150.8M 129.4M 141.8M 157.5M 188.3M
Non-Current Liabilities 55.9M 41.8M 43.6M 63.8M 96.4M
Total Liabilities 206.7M 171.2M 185.3M 221.2M 284.8M
Equity
Total Shareholders Equity 535.7M 508.4M 456.3M 403.1M 368.9M

Balance Sheet Composition

Mercury Laboratories Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 46.6M 69.2M 74.4M 50.3M 79.1M
Operating Cash Flow -12.6M 78.6M 16.1M 93.3M 42.2M
Investing Activities
Capital Expenditures -90.4M -62.7M -10.6M -18.9M -46.2M
Investing Cash Flow -90.4M -62.7M -10.6M -18.9M -46.2M
Financing Activities
Dividends Paid -4.2M -4.2M -4.2M -2.4M -4.2M
Financing Cash Flow -19.2M -6.9M -2.1M -5.7M -5.1M
Free Cash Flow -50.4M 19.5M 14.0M 32.7M 35.9M

Cash Flow Trend

Mercury Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 31.53
Price to Book 1.85
Price to Sales 1.32

Profitability Ratios

Profit Margin 4.19%
Operating Margin 7.57%
Return on Equity 6.02%
Return on Assets 4.58%

Financial Health

Current Ratio 2.66
Debt to Equity 10.18
Beta 0.54

Per Share Data

EPS (TTM) ₹26.20
Book Value per Share ₹446.25
Revenue per Share ₹625.90

Financial data is updated regularly. All figures are in the company's reporting currency.